ALLIANCE FOR REGENERATIVE MEDICINE

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

TIMOTHY HUNT

Phone

8444712200

Tax Period

2024-01-01 to 2024-12-31

ALLIANCE FOR REGENERATIVE MEDICINE, founded in 2009, is a mid-sized nonprofit in the Medical Research sector that reported $18.4M in total revenue in fiscal year 2024. Revenue grew 11% year-over-year, indicating healthy expansion. Expenses of $17.1M left a modest 7% surplus.

Mission

THE ALLIANCE FOR REGENERATIVE MEDICINE (ARM) IS THE PREEMINENT GLOBAL ADVOCATE FOR REGENERATIVE AND ADVANCED THERAPIES. ARM FOSTERS RESEARCH, DEVELOPMENT, INVESTMENT AND COMMERCIALIZATION OF TRANSFORMATIONAL TREATMENTS AND CURES FOR PATIENTS WORLDWIDE. BY LEVERAGING THE EXPERTISE OF ITS MEMBERSHIP, ARM EMPOWERS MULTIPLE STAKEHOLDERS TO PROMOTE LEGISLATIVE, REGULATORY, AND PUBLIC UNDERSTANDING OF, AND SUPPORT OF, THIS EXPANDING FIELD.

Program Service Accomplishments

Program 1

Expenses: $5,993,146 Revenue: $92,080

PUBLIC AFFAIRS, ADVOCACY, AND COMMUNICATIONS: GLOBAL PUBLIC AFFAIRS (GPA) IS AN ALIGNMENT OF MARKET READINESS, PREPARATION AND CONDITIONING STRATEGIES (PRE-COMMERCIAL) IN THE UNITED STATES AND EUROPE THAT IS COMPLEMENTARY TO THE REIMBURSEMENT AND REGULATORY NEEDS OF OUR MEMBER ORGANIZATIONS, AND ULTIMATELY ACHIEVING PATIENT ACCESS TO OUR INNOVATIONS. THE FUNCTION IS ALSO THE STEWARD OF ARM'S BRAND AND REPUTATION. TACTICALLY, GPA PROVIDES COMPREHENSIVE, CENTRALIZED, AND CONSISTENT SUPPORT ON KEY ALLIANCE INITIATIVES AND OBJECTIVES AND ENGAGES WITH STAKEHOLDERS TO CONTINUE TO SUSTAIN LEGITIMACY BY SAFEGUARDING ARM'S IMAGE AND REPUTATION IN A HOSTILE POLITICAL AND REGULATORY ENVIRONMENT.

Program 2

Expenses: $5,282,726 Revenue: $9,118,509

EVENTS: TO CONVENE BOTH ARM MEMBERS AND NON-MEMBERS TO PROMOTE COMMERCIAL, ETHICAL, SCIENTIFIC, AND GOVERNMENT AFFAIRS EXCHANGE SURROUNDING THE CELL AND GENE THERAPY SECTOR.

Program 3

Expenses: $1,990,470 Revenue: $220,570

SCIENCE AND TECHNOLOGY: TO DEVELOP CONSENSUS PRODUCT DEVELOPMENT, REGULATORY STANDARDS, AND PROVIDE MORE EFFICIENT ACCESS TO INDUSTRY BEST-PRACTICES REGARDING MANUFACTURING AND SCALE-UP.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $421,080

Program Service Revenue $17,548,955

Investment Income $472,512

Other Revenue $0

TOTAL REVENUE $18,442,547

Expense Breakdown

Grants Paid $25,000

Salaries & Benefits $6,492,854

Fundraising Expenses $0

Program Expenses $14,447,269

Other Expenses $10,544,657

TOTAL EXPENSES $17,062,511

Year-over-Year Comparison

	2024	2023	Change
Revenue	$18,442,547	$16,682,407	+0.1%
Expenses	$17,062,511	$17,686,270	0.0%
Net Income	$1,380,036	$-1,003,863	-2.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,705,581

Total Directors

Key Employees

$627,734

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DEVYN SMITH	CHAIR	2.00	Officer Director	$0	$0	$0
CHRISTOPHER VANN	TREASURER	2.00	Officer Director	$0	$0	$0
FARAZ ALI	DIRECTOR	0.31	Director	$0	$0	$0
ROBERT ANG	DIRECTOR	0.31	Director	$0	$0	$0
CATHERINE BOLLARD	DIRECTOR	0.31	Director	$0	$0	$0
AMY BUTLER	DIRECTOR	0.31	Director	$0	$0	$0
BRADLEY CAMPBELL	DIRECTOR	0.31	Director	$0	$0	$0
MIGUEL FORTE	DIRECTOR	0.31	Director	$0	$0	$0
BRETT KOPELAN	DIRECTOR	0.31	Director	$0	$0	$0
ANN LEE	DIRECTOR	0.31	Director	$0	$0	$0
TIM LU	DIRECTOR	0.31	Director	$0	$0	$0
JOHN MASLOWSKI	DIRECTOR	0.31	Director	$0	$0	$0
CHRIS MASON	DIRECTOR	0.31	Director	$0	$0	$0
ADORA NDU	DIRECTOR	0.31	Director	$0	$0	$0
SUSAN NICHOLS	DIRECTOR	0.31	Director	$0	$0	$0
KARAH PARSCHAUER	DIRECTOR	0.31	Director	$0	$0	$0
JACOB PETERSON	DIRECTOR	0.31	Director	$0	$0	$0
LOUISE RODINO-KLAPAC	DIRECTOR	0.31	Director	$0	$0	$0
JEFF ROSS	DIRECTOR	0.31	Director	$0	$0	$0
ALBERTO SANTAGOSTINO	DIRECTOR	0.31	Director	$0	$0	$0
LAURA SEPP-LORENZINO	DIRECTOR	0.31	Director	$0	$0	$0
BOB SMITH	VICE CHAIR	0.31	Officer Director	$0	$0	$0
KRISTIN YAREMA	SECRETARY	0.31	Officer Director	$0	$0	$0
CURRAN SIMPSON	DIRECTOR	0.31	Director	$0	$0	$0
SAMUELE BUTERA	DIRECTOR AS OF 01/24	0.31	Director	$0	$0	$0
MOYA DANIELS	DIRECTOR AS OF 01/24	0.31	Director	$0	$0	$0
LISA DESCHAMPS	DIRECTOR AS OF 01/24)	0.31	Director	$0	$0	$0
DEBBIE DRANE	DIRECTOR AS OF 01/24	0.31	Director	$0	$0	$0
AUDREY GREENBERG	DIRECTOR AS OF 01/24	0.31	Director	$0	$0	$0
MATT KAPUSTA	DIRECTOR AS OF 01/24	0.31	Director	$0	$0	$0
ANSHUL MANGAL	DIRECTOR AS OF 01/24	0.31	Director	$0	$0	$0
RICHARD WILSON	DIRECTOR AS OF 01/24	0.31	Director	$0	$0	$0
KINNARI PATEL	DIRECTOR	0.31	Director	$0	$0	$0
TIMOTHY HUNT	CHIEF EXECUTIVE OFFICER	40.00	Officer	$660,447	$23,928	$684,375
MARK BATTAGLINI	CHIEF STRATEGY OFFICER	40.00	Officer	$527,890	$41,451	$569,341
TREERITA JOHNSON-GREENE	COO	40.00	Officer	$436,375	$15,490	$451,865
ERICA CISCHKE	VP, GOVT AFFAIRS	40.00	Key Emp	$285,494	$13,007	$298,501
MICHAEL LEHMICKE	SVP, SCIENCE AND INDUSTRY	40.00	Key Emp	$295,421	$33,812	$329,233
STEPHEN MAJORS	SR DIRECTOR GLOBAL COMMS	40.00	Highest	$239,013	$20,506	$259,519
LAURA C STRINGHAM	VP, MEMBERSHIP AND EVENTS	40.00	Highest	$214,304	$29,479	$243,783
MONICA VELDMAN	DIRECTOR, GLOBAL REGULATORY POLICY	40.00	Highest	$214,010	$13,393	$227,403
MONET STANFORD	DIRECTOR, ACCESS AND REIMBUR. POLICY (AS OF 11/24)	40.00	Highest	$173,178	$15,410	$188,588
ROBIN MUTHIG	SENIOR DIRECTOR, MEMBERSHIP	40.00	Highest	$159,400	$12,920	$172,320

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$18,442,547	$17,062,511	$12,956,950	$1,380,036
2023	$16,682,407	$17,686,270	$10,981,787	$-1,003,863
2023	$16,682,407	$17,686,270	$10,981,787	$-1,003,863
2022	$15,363,952	$14,473,175	$11,865,378	$890,777
2021	$10,904,376	$8,797,945	$10,715,700	$2,106,431
2020	$6,001,597	$4,853,622	$6,599,217	$1,147,975
2019	$7,532,037	$5,976,518	$4,673,709	$1,555,519
2018	$5,089,429	$4,762,567	$2,877,756	$326,862